LIFECORE BIOMEDICAL, INC. Payments to Acquire Investments
LIFECORE BIOMEDICAL, INC. (LFCR) reported Payments to Acquire Investments of $18.00 million for the 12-month period ending 2015-05-31, per its 10-K/A filed 2018-03-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2018-03-15
- LIFECORE BIOMEDICAL, INC. payments to acquire investments for the quarter ending 2015-05-31 was $0.00.
- LIFECORE BIOMEDICAL, INC. payments to acquire investments for the quarter ending 2015-03-01 was $0.00.
- LIFECORE BIOMEDICAL, INC. payments to acquire investments for the quarter ending 2014-11-30 was $7.00M.
- LIFECORE BIOMEDICAL, INC. payments to acquire investments for the quarter ending 2014-08-31 was $11.00M.
- LIFECORE BIOMEDICAL, INC. payments to acquire investments for fiscal 2015 was $18.00M.
- LIFECORE BIOMEDICAL, INC. payments to acquire investments for fiscal 2011 was $15.00M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2015-05-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $7.00M derived: sum of 3 quarters · filed 2018-03-15 | $18.00M 10-K/A · filed 2018-03-15 |
| 2015-03-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $7.00M derived: sum of 2 quarters · filed 2016-03-30 | $18.00M 10-Q · filed 2016-03-30 | |
| 2014-11-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07 | $18.00M 10-Q · filed 2016-01-07 | ||
| 2014-08-31 | $11.00M 10-Q · filed 2015-10-01 | |||
| 2011-05-29 | $15.00M 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |